The AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing

Stephen Onikoro of PharmaForceIQ joins four other industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.

The roundtable, steered by Sharlene Jenner, vice president of engagement strategy for Abelson Taylor, dives into the implications of AI’s rapid evolution through an exploration of present-day applications of AI in pharma marketing and commercial activities, as well as the associated ethical and regulatory challenges.

“From our perspective of helping pharmaceutical marketers in HCP marketing, we see AI becoming more a part of the transactional aspects of what pharmaceutical marketers do. For example, segmentation,” says Onikoro. “We’re not just looking at huge segments, but we’re looking at micro-segments and tailoring messages specifically to them.”

Featured in the July 2023 issue of Pharmaceutical Executive (Volume 43, Issue 7), you can read the full article here at pharmexec.com.